Fig. 1: Patient flow diagram and study design. | Genetics in Medicine

Fig. 1: Patient flow diagram and study design.

From: Tasimelteon safely and effectively improves sleep in Smith–Magenis syndrome: a double-blind randomized trial followed by an open-label extension

Fig. 1

(a) CONSORT patient flow diagram. (b) The study consisted of a randomized, placebo-controlled, two-phase crossover treatment arm and a parallel open-label treatment arm for patients who did not qualify for the randomization treatment period. Both the randomization and open-label treatment arms were followed by an open-label extension phase.

Back to article page